• Citer

The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.

par Aygun Kocabas, Neslihan ;Faghel, Carole ;Barreto, Mara Isabel ;Kasper, Siegfried;Linotte, Sylvie ;Mendlewicz, Julien ;Noro, Magali ;Oswald, Pierre ;Souery, Daniel ;Zohar, Joseph;Massat, Isabelle
Référence International clinical psychopharmacology, 25, 4, page (218-227)
Publication Publié, 2010-07

Article révisé par les pairs

• Détails
• Contenu

Titre:	The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
Auteur:	Aygun Kocabas, Neslihan; Faghel, Carole; Barreto, Mara Isabel; Kasper, Siegfried; Linotte, Sylvie; Mendlewicz, Julien; Noro, Magali; Oswald, Pierre; Souery, Daniel; Zohar, Joseph; Massat, Isabelle
Informations sur la publication:	International clinical psychopharmacology, 25, 4, page (218-227)
Statut de publication:	Publié, 2010-07
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Antidepressant
	Catechol-O-methyltransferase
	Haplotype
	Major depressive disorder
	Single nucleotide polymorphisms
	Treatment response phenotype
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0268-1315
	info:doi/10.1097/YIC.0b013e328338b884
	info:scp/77953721854
	info:pmid/20531207